1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | S1 added there has never been an instance where medications were not available or delayed.
During the initial complaint visit conducted by the Department on December 14, 2023, it was observed Miralax was available at the facility. When the Department questioned who the Miralax belong to, staff stated it belonged to Resident 7 (R7). The Department did not observe Miralax in R7's medication administration record. The staff removed the Miralax from the facility and stated they would obtain a physician's order to provide to R7. Record review revealed R7 moved out of the facility on October 14, 2024. LPA reviewed R7's medication administration record for the months of September, October, and November 2023. LPA also reviewed medication list from hospice for R7 dated October 7, 2023. Neither indicates Miralax or Polyethylene Glycol Powder as part of R7's medications.
Regarding the allegation facility failed to maintain a complete and accurate resident’s records, it was reported resident records and not maintained per Title 22 regulations. The centrally stored medication and destruction record for R7 was not available to review. Administrator (AD) Kian Pascual stated those records were lost when the facility transitioned into their current record keeping system.
Based on interviews conducted, records reviewed, and observations, the preponderance of evidence standard has been met. Therefore, the above allegations are found to be SUBSTANTIATED.
California Code of Regulations, (Title 22, Division 6), are being cited on the attached LIC 9099D.
An exit interview was conducted and a copy of the report was left with the facility representative along with appeal rights. |